Autres langues Amotiv Limited

Actions

Marché Fermé - Australian S.E. Autres places de cotation 08:10:18 01/07/2024			Varia. 5j.	Varia. 1 janv.
10,42 ^AUD	-0,76%		-6,63%	-13,17%

25/06	Le changement de nom de GUD Holdings prend effet	MT
19/06	France-Darmanin va proposer de dissoudre le GUD	RE

France's election stokes far-right linked violence	28/06
GUD Holdings' Name Change Takes Effect	25/06
World shares little changed ahead of US inflation data	14/05
Asia shares hit 15-month high as traders wait for CPI	14/05
Asia shares hit 15-month high as traders wait for CPI	14/05
GUD Holdings Says on Track to Achieve at Least AU$193.5 Million in EBITA in Fiscal 2024	14/05
Knight Therapeutics Reports Fourth Quarter Results	21/03
Knight Therapeutics Announces Launch of Minjuvi in Brazil	29/02
GUD Holdings Posts 20% Jump in Fiscal H1 Net Profit as Revenue Rises 9%	14/02
Gud Holdings Limited Declares Interim Dividend	13/02
GUD Holdings Limited Seeks Bolt-On Acquisitions	13/02
GUD Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	13/02
Knight Therapeutics Announces Launch of Bijuva in Canada	06/02
Knight Therapeutics Enters Into License Agreement With Amneal Pharmaceuticals For Parkinson's Disease Treatment	25/01
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	04/01
Knight Therapeutics in Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree in Canada	19/12
GUD Holdings Completes Rindab Acquisition	02/11
GUD Holdings Acquiring European Lighting Distribution Business for AU$12 Million	17/10/23
Knight Therapeutics Announces CMED Price Approval of Minjuvi in Brazil	16/10/23
Knight Therapeutics Seeking Brazilian Approvals for the Pemigatinib Cancer Treatment	10/10/23

Aucun résultat pour cette recherche